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Abstract
Background: Mortality and morbidity are hardly documented in the white veal industry, despite high levels of
antimicrobial drug use and resistance. The objective of the present study was to determine the causes and
epidemiology of morbidity and mortality in dairy, beef and crossbred white veal production. A total of 5853 calves,
housed in 15 production cohorts, were followed during one production cycle. Causes of mortality were
determined by necropsy. Morbidity was daily recorded by the producers.
Results: The total mortality risk was 5,3% and was significantly higher in beef veal production compared to dairy
or crossbreds. The main causes of mortality were pneumonia (1.3% of the calves at risk), ruminal disorders (0.7%),
idiopathic peritonitis (0.5%), enterotoxaemia (0.5%) and enteritis (0.4%). Belgian Blue beef calves were more likely to
die from pneumonia, enterotoxaemia and arthritis. Detection of bovine viral diarrhea virus at necropsy was
associated with chronic pneumonia and pleuritis. Of the calves, 25.4% was treated individually and the morbidity
rate was 1.66 cases per 1000 calf days at risk. The incidence rate of respiratory disease, diarrhea, arthritis and otitis
was 0.95, 0.30, 0.11 and 0.07 cases per 1000 calf days at risk respectively. Morbidity peaked in the first three weeks
after arrival and gradually declined towards the end of the production cycle.
Conclusions: The present study provided insights into the causes and epidemiology of morbidity and mortality in
white veal calves in Belgium, housed in the most frequent housing system in Europe. The necropsy findings,
identified risk periods and differences between production systems can guide both veterinarians and producers
towards the most profitable and ethical preventive and therapeutic protocols.
Keywords: Veal calves, Mortality, Morbidity, Respiratory disease, Bovine viral diarrhea virus, Arthritis, Enteritis,
Peritonitis
Background
The white veal industry is specialized in rearing calves
from different breed and origin on a low-iron milk powder
diet. The industry is highly integrated and Europe pro-
duces about 6 million veal calves yearly, raised predomi-
nantly in France, the Netherlands, Italy and Belgium [1].
The incidence of calf diseases differs between production
systems and geographical locations and varies over time
[2-9]. Therefore collection of local and temporal data is to
be preferred. In contrast to conventional dairy, beef, suck-
ler and feedlot calves, mortality and morbidity is hardly
documented in veal calves. Previous studies addressed
mortality in veal calves housed in individual stalls (crates)
in the United States and Canada [10-12]. This housing sys-
tem has been completely abandoned in Europe (Council
Directives 91/629/EC and 97/2/EC) and in certain states
in the United States. The only recent European study
addressed a niche production system with an exceptionally
high animal welfare standard in Switzerland, a minor pro-
ducing country [13]. White veal production can be divided
into three production systems, based upon the type of calf
that is reared, namely dairy, beef or crossbred veal. These
systems do not only differ according to the selected
breeds, but also have a different nutritional and organiza-
tional management. Previous studies only addressed dairy
calves, whereas in several countries also the other produc-
tion systems are present [10,13].
No contemporary study on morbidity and mortality in
the most frequent veal housing system of the European
mainland, which is group housing on slatted floors in
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pens of 2 to 8 animals after a 6 weeks period of indivi-
dual housing, is currently available. Nowadays such a
study is of particular interest, since multidrug resistance
is abundantly present in the veal industry and of great
public concern [14-20]. Additionally a recent study
showed that antimicrobial use in the veal industry is
highest of all food producing animals [21]. All these
observations force the veal industry to evaluate current
treatment protocols and search for alternative
approaches. Longitudinal mortality and morbidity data
provide essential information for the understanding of
current practices and their consequences in white veal
calves, and can form the basis for novel preventive
strategies.
Therefore, the objective of the present field study was
to determine the causes and epidemiology of mortality
and morbidity in white veal calves, housed within differ-
ent production systems.
Methods
Study design, selection of herds and animals
A prospective longitudinal survey based on a sample of
5% of the Flemish veal herds was conducted to monitor
all morbidity and mortality events in one production
cycle per herd. The study population consisted of all
veal herds in Flanders (Northern Belgium) certified by
the Belgian Controlled Veal (BCV) label. The sampling
frame was the list of veal herds in Flanders officially
registered in the Belgian cattle registration system
(SANITEL, Animal Health Service-Flanders). Of the 295
herds in Belgium, 285 herds (97%) are situated in Flan-
ders and 271 herds (95%) complied with the BCV label.
Because of the intensive registration, the routine visiting
and reporting necessary, farms were conveniently
selected. Selection criteria included the willingness to
keep detailed registration records on diseases and treat-
ment and allowing the use of farm data. Selection was
independent of any disease history and for logistic rea-
sons the farms were gradually initiated in the study over
a 2 year period. A production cohort was defined as one
all in all out production cycle, which lasted from arrival
to slaughter (6-8 months). The study group consisted of
15 production cohorts, in 15 herds. The sample was
stratified on production system: dairy (n = 5), crossbred
(n = 5) and beef (n = 5) cohorts.
Data collection
Registration of mortality data and definitions
All calves were individually identified by ear tag, accord-
ing to Belgian law. Calf arrival data were collected from
the Belgian cattle registration system (SANITEL–Animal
Health Service–Flanders). The reasons for calves not fin-
ishing the production cycle were death, culling (=
unwanted early slaughter) or transfer to another
production system. The latter category included calves
which were unable to adapt to the intensive milk diet or
the concentrate replacer diet and were removed from the
veal stables to be fattened as conventional calves.
Unwanted early slaughter was defined as calves being
individually slaughtered before the rest of the group,
mostly for reasons of trauma or sudden respiratory symp-
toms. Calf identity, mortality date and preceding symp-
toms were recorded on registration forms by the
producers. A gross postmortem examination of the ani-
mals which died during production was performed either
on farm by a specialized veterinarian or at the Animal
Health Service-Flanders. For these postmortem examina-
tions a standardized protocol was always followed. For
data processing only one cause of mortality was regis-
tered. If more than one lesion was present, the most
severe lesion was used as reason of death. If an obvious
reason for the animals death was known from the ana-
mnesis (e.g. shock as a consequence of parenteral iron
administration) and the autopsy findings complied with
this diagnosis, the animal was classified as such. The
group of respiratory diseases included two gross diag-
noses: pneumonia and necrobacillosis (laryngeal
diphtheria). Pneumonia was only held responsible for the
animals death if more than one third of the lung was
affected, and other lethal lesions were absent. Also pneu-
monia cases with concurrent pleuritis or pericarditis but
without peritonitis (see definition polyserositis under-
neath) were classified as pneumonia cases. Calves which
suffocated as a consequence of air way blockage by
necrotic lesions upon the vocal cords/arytenoids were
classified as necrobacillosis. The group of digestive dis-
eases included acute ruminal disorders, enteritis, entero-
toxaemia, mesenteric torsion, intussusception, liver
disease, abomasal hemorrhage and peritonitis due to per-
forating abomasal ulceration. Ruminal disorders included
all acute ruminal pathology (frothy bloat and acute rum-
inal acidosis/rumenitis) causing sudden death. Cases
were classified as enteritis when a macroscopic enteritis
and obvious smearing of the hind legs were present at
necropsy. Enterotoxaemia was defined as the presence of
an extensive necrohaemorrhagic enteritis. Calves were
classified as idiopathic peritonitis if at least a peritonitis,
without an obvious internal cause (e.g. perforating abo-
masal ulceration, intussusception,...) was present. This
group includes cases in which besides a peritonitis also
pericarditis and pleuritis were present (polyserositis).
Liver disease included hepatitis, severe hepatic steatosis
and generalized icterus. Cases in which the liver was
involved in an omphaloflebitis were classified as omphalitis
cases, together with omphalitis as such, omphalo-
urachitis, omphaloarteritis and umbilical abscesses. Septice-
mia as such was not determined, and cases which presum-
ably died due to septicemia were classified according to the
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major lesion (omphalitis, enteritis, meningitis or pneumo-
nia). The group of neurological disorders included hydra-
nencephalia, hydrocephalus and meningitis. The group of
orthopedic diseases included euthanasia due to severe
arthritis, limb or vertebral column fractures and death due
to accidental hanging. Only when necropsied at the Animal
Health Service hearts were examined and calves with con-
genital heart defects were classified as such. Calves which
died suddenly and did not show obvious findings of any of
the above mentioned acute diseases at necropsy, besides a
mild (hemorrhagic) enteritis, were classified as sudden
death of unknown origin. Calves which were dead on arri-
val or died the first day after arrival, were classified as dead
on arrival. Calves that were not autopsied (e.g. due to
extensive postmortal decay), were classified as such.
Detailed necropsies and additional virological and
bacteriological investigations
For calves necropsied at the Animal Health Service, histo-
pathology was performed in case no gross diagnosis was
possible. Additionally, samples for bacteriological and viro-
logical examination were taken. In cases of neonatal enter-
itis a commercial antigen ELISA for Cryptosporidium
parvum, bovine coronavirus, bovine rotavirus and Escheri-
chia coli (F5) was performed on intestinal content (Diges-
tive ELISA kit, Bio-X, Jemelle, Belgium). Isolation of
Salmonella spp. was attempted in cases with suspicious
lesions, by aerobically culturing intestinal content on brilli-
ant green agar plates (Lab-M, Bury, UK). Isolation of
respiratory bacteria (Pasteurellaceae and Mycoplasma
spp.) from pneumonia lesions was performed according to
standard protocols, described elsewhere [22-24]. The pre-
sence of bovine viral diarrhea virus (BVDV) was examined
by PCR on spleen tissue [25]. For selected cases of acute
pneumonia PCR analysis for bovine herpesvirus 1 (BHV-
1) [26] and bovine respiratory syncytial virus (bRSV) [27]
together with virus isolation for bovine adenovirus 3
(BAV-3) and parainfluenzavirus type 3 (PI-3) was per-
formed at the Veterinary and Agrochemical Research Cen-
tre (CODA-CERVA, Ukkel, Belgium) according to in
house standard protocols, described elsewhere [24].
Registration of morbidity data and definitions
Morbidity was estimated on the bases of individual treat-
ment of the calves. A calf was considered a case of a given
disease, when treated individually for that indication on at
least one day by the producer or veterinarian. This treat-
ment included both single or multiple, antimicrobial or
non-antimicrobial drugs. An initial case was defined as the
first treatment of a calf for a given indication. A reoccur-
ent case was defined as a calf receiving a new treatment
for the same indication more than 5 and less than 15 days
after the last treatment for that indication. A relapse case
was defined as a calf receiving a new treatment for the
same indication more than 14 days after the last treatment
for that indication [28]. Data were collected on the bases
of the daily recording of individual treatments by the pro-
ducers on preprinted registration forms. Treatments per-
formed by the veterinarian were also registered on the
same forms. The following diagnostic reasons for indivi-
dual treatment were optioned: (bovine) respiratory disease
(BRD), diarrhea, idiopathic peritonitis, acute ruminal dis-
order, ruminal drinking, otitis, arthritis, omphalitis, laryn-
geal necrobacillosis, nervous symptoms and miscellaneous.
Herds were visited by the primary investigator between 4
and 8 times during the registration period in order to
check compliance with the recording system.
Data management and statistical analysis
Mortality and morbidity (treatment) data were entered in
a relational data base (Access 2007, Microsoft Inc.,
Washington, DC) and transferred to SAS version 9.1
(SAS Institute Inc., Cary, NC) for descriptive and statisti-
cal analysis. Mortality data were consistent for 5853
calves. Treatment records (morbidity) were judged as
unreliable on 5 cohorts, because of inconsistencies with
calf identification. Therefore morbidity data was limited
to 3519 calves from 10 cohorts. Mortality/morbidity risks
were calculated as the number of mortalities/diseased
calves over the number of calves at risk at the start of the
study. Mortality/morbidity rates were calculated as the
number of mortalities/diseased calves (initial and relapse)
over the number of calf-days-at-risk [28,29]. Reoccurent
cases (within 14 days after initial treatment) were consid-
ered as a failure of initial treatment and therefore not
included in the calculations of morbidity risks and rates.
For mortality a calf was considered at risk when present
alive in the cohort. For morbidity a calf was considered at
risk when present alive in the cohort and not individually
treated in the past 14 days for the indication of interest
[28]. In this respect days spend on oral group antimicro-
bial treatments were not taken into account. The long
acting effect of certain antimicrobial formulations was
taken into account by counting one injection as 2 (tilmi-
cosin, amoxicillin, florfenicol, danofloxacin) or 9 days
(tulathromycin) of treatment. The proportion of reoccur-
ent and relapse cases was calculated by dividing the num-
ber of reoccurent/relapse cases by the number of initial
cases for each cohort. In the same way, the fatality rate
was calculated as the number of fatal cases of a given dis-
ease over the number of initial cases.
Because calves are reorganized according to drinking
speed several times per production cycle, analysis at the
compartment and pen level was not possible. The unit of
analysis was the individual calf. To analyze relationships
between production system (dairy, beef or crossbred) and
mortality, separate multivariable Cox proportional hazard
models were built, with total mortality, pneumonia,
enteritis, ruminal disorders, enterotoxaemia, idiopathic
peritonitis, death at arrival, abomasal hemorrhage,
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perforating abomasal ulceration and arthritis as binary
outcome variables. The PROC PHREG statement was
used, including the positive stable frailty models in the
SAS macro to account for clustering within a herd [30].
The end of the observation period was the date of slaugh-
ter, if death had not occurred.
To analyze the effect of the production system on
morbidity, separate multivariable models were fit with
total morbidity, BRD, enteritis, otitis and arthritis as bin-
ary outcome variables. PROC GLIMMIX with binomial
distribution and logit link function with Wald’s statistics
for type 3 contrasts was used with herd as random
effect. Associations between the different pathological
lesions (pneumonia (acute-chronic-pulmonary abscess),
enteritis (catarrhal-hemorrhagic), pleuritis, pericarditis,
abomasal ulceration, ruminal bloat and peritonitis) and
between the lesions and additional diagnostic test results
(BVDV PCR and bacteriology of lung lesions) were
determined by logistic regression (PROC GLM). Signifi-
cance was set at P < 0.05.
Results
Description of study herds composition and management
Herds entered the study between October 2007 and Octo-
ber 2009. A total of 5853 calves was followed (2744 on
dairy cohorts, 1624 on crossbred cohorts and 1485 on beef
cohorts). Calves on dairy cohorts were predominantly
black and red Holstein Friesian (HF), whereas calves on
beef cohorts were exclusively Belgian Blue (BB) double
muscled calves. In crossbred cohorts, predominantly
HFxBB crossbreds were housed. Mean herd size of the
selected herds was 679 (standard deviation (SD) = 334),
which was comparable to the sampling frame (Student’s
t-test, P = 0.22). The average number of calves in the fol-
lowed cohorts was 390 (SD = 167). The sample contained
calves from the three main integrators in Belgium (n =
4797) and from 3 smaller integrators (n = 1056). The 15
herds were under supervision of 5 different veterinary
practices. The production cycle length was 196.4 days on
average (SD = 9.2; Range (R)(min.-max.) = 174.9-211.0).
Calves belonging to the same production cohort were
housed in the same stable, which was divided into differ-
ent compartments in all but two herds. All calves were
individually housed during the first 6 weeks and thereafter
group housed in galvanized pens on slatted floors. The
diet was different between the three production systems.
Dairy calves started on a 50/50 ratio with skimmed milk
powder and so called nil product (whey and vegetable pro-
teins), which changed to 100% nil product at 8 weeks post
arrival on average. Crossbreds received higher quality
skimmed milk powder in the first weeks, but eventually
also reached a 100% nil product diet. On the contrary,
beef calves never reached 100% nil product, and predomi-
nantly received high quality skimmed milk powder. In
addition, concentrates and fibers were provided in each
production system. Calves were not vaccinated against any
pathogen.
Descriptive epidemiology of mortality
Overall, 308 calves (5.3%) died during production and
0.3% was unwanted early slaughtered. Unwanted early
slaughter only occurred on 3 beef cohorts, ranging from
0.6 to 3.8% of the calves. Of the calves that died, on aver-
age 82.3% (253/308) was necropsied, ranging from 47.1
to 100.0% at the cohort level. The main reason for not
necropsying a calf was the producer neglecting to timely
inform the veterinarian, resulting in too advanced post-
mortal decay for interpretation. The non-necropsied
calves also included the calves which were classified as
‘death at arrival’ (3.6% (11/308)) for the same reason.
Overall, the digestive system accounted for 41.9% of mor-
tality, the respiratory system for 27.7%, the musculoskele-
tal system for 3.6%, the nervous system for 2.0% and
idiopathic peritonitis as such for 14.6%. The leading indi-
vidual causes of mortality were pneumonia (on average
27.0% of the losses at the cohort level; SD = 14.4; R =
7.7-62.5), ruminal disorders (18.6%; SD = 14.4; R = 0-
44.4), idiopathic peritonitis (11.9%; SD = 14.3; R = 0-
51.5), enterotoxaemia (10.0%; SD = 10.6; R = 0-38.5) and
enteritis (9.6%; SD = 8.3; R = 0-25.0%). Mortality risks
and rates for the different causes of mortality are listed
by production system in Table 1. Overall, the mortality
risk was highest in the first weeks after arrival, gradually
declined until week 12 and increased again at the end of
the production cycle (Figures 1 and 2). Overall, mortality
was higher in beef cohorts compared to dairy (hazard
ratio (HR) = 1.6; confidence interval (CI) = 1.0-2.5; P <
0.05) or crossbred cohorts (HR = 2.3; CI 1.5-3.9; P <
0.01) (Figure 3).
Three major peaks in total mortality could be identified
(Figures 1 and 2). The first and highest one occurred at
week two and in that week the most important causes of
mortality were pneumonia (27.3%), enteritis (22.7%),
hydranencephalia (13.6%) and omphalitis (13.6%). Mor-
tality due to pneumonia peaked between week 2 and 6,
but continued at lower level throughout the entire cycle
(Figure 1). Calves housed in beef cohorts were more
likely to die from pneumonia compared to dairy calves
(HR = 2.5; CI = 1.1-5.8; P < 0.05) and crossbreds (HR =
3.2; CI = 1.3-8.0; P < 0.05). The second peak, at week 9,
was mainly due to idiopathic peritonitis (Figure 1). Idio-
pathic peritonitis occurred on 66,7% of the studied
cohorts. There was no significant influence of the pro-
duction system on mortality due to idiopathic peritonitis.
However, whereas sporadic cases of idiopathic peritonitis
occurred in crossbred and beef cohorts, larger outbreaks
(0.4 to 2.0% of the calves) occurred in 4 of the 5 dairy
cohorts. The third peak was situated at the end of the
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Table 1 Mortality risk (%) and rates (cases per 1000 days at risk) in white veal calves by production system (15 cohorts, 5853 calves, 2007-2009, Belgium)
Cause of mortality Total (n = 5853) Dairy (n = 2744) Crossbreds (n = 1624) Beef (n = 1485)
Percentage of cohorts affected Mortality risk
mean ± SD
(min-max)
Mortality rate
mean ± SD
(min-max)
Mortality risk
mean ± SD
(min-max)
Mortality rate
mean ± SD
(min-max)
Mortality risk
mean ± SD
(min-max)
Mortality rate
mean ± SD
(min-max)
Mortality risk
mean ± SD
(min-max)
Mortality rate
mean ± SD
(min-max)
Total mortality 100.0 5.3 ± 2.5
(1.8-10.9)
0.27 ± 0.13
(0.09-0.58)
4.9 ± 0.8
(3.9-5.7)
0.25 ± 0.030
(0.22-0.28)
3.5 ± 1.6
(1.8-5.3)
0.18 ± 0.08
(0.09-0.27)
7.5 ± 3.0
(4.8 ± 10.9)
0.38 ± 0.16
(0.25-0.58)
Pneumonia 100.0 1.3 ± 1.1
(0.3-3.5)
0.07 ± 0.06
(0.01-0.18)
0.9 ± 0.5
(0.5-1.8)
0.05 ± 0.03
(0.03-0.09)
0.7 ± 0.3
(0.3-1.2)
0.03 ± 0.02
(0.15-0.06)
2.3 ± 1.5
(0.3-3.5)
0.02 ± 0.08
(0.01-0.18)
Ruminal disorders 86.7 0.7 ± 0.6
(0-2.2)
0.04 ± 0.03
(0-0.11)
0.8 ± 0.6
(0.2-1.6)
0.04 ± 0.03
(0.01-0.08)
0.8 ± 0.8
(0.2-2.2)
0.04 ± 0.04
(0.01-0.11)
0.6 ± 0.6
(0-1.2)
0.03 ± 0.03
(0-0.06)
Enterotoxaemia 66.7 0.5 ± 0.7
(0-2.2)
0.03 ± 0.03
(0-0.11)
0.2 ± 0.2
(0-0.4)
0.01 ± 0.01
(0-0.02)
0.2 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.03)
1.3 ± 0.7
(0.5-2.2)
0.06 ± 0.04
(0.03-0.11)
Idiopathic peritonitis 73.3 0.5 ± 0.6
(0-2.1)
0.02 ± 0.03
(0-0.10)
0.8 ± 0.8
(0-2.1)
0.04 ± 0.04
(0-1.10)
0.3 ± 0.3
(0-0.6)
0.01 ± 0.01
(0-0.03)
0.3 ± 0.3
(0-0.8)
0.01 ± 0.02
(0-0.04)
Enteritis 80.0 0.4 ± 0.3
(0-1.3)
0.02 ± 0.02
(0-0.06)
0.3 ± 0.3
(0-0.7)
0.02 ± 0.02
(0-0.04)
0.3 ± 0.3
(0-0.6)
0.01 ± 0.01
(0-0.03)
0.6 ± 0.4
(0.2-1.3)
0.03 ± 0.02
(0.01-0.06)
Death at arrival 20.0 0.3 ± 0.7
(0-2.2)
0.01 ± 0.03
(0-0.11)
< 0.1 ± 0.1
(0-0.1)
< 0.01 ± 0.00
(0-0.01)
0.4 ± 1.0
(0-2.2)
0.02 ± 0.05
(0-0.11)
0.3 ± 0.7
(0-1.6)
0.02 ± 0.04
(0-0.08)
Arthritis 26.7 0.1 ± 0.3
(0-1.0)
0.01 ± 0.01
(0-0.05)
0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- - 0.3 ± 0.4
(0-1.0)
0.01 ± 0.02
(0-0.05)
Abomasal hemorrhage 26.7 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
0.0 ± 0.1
(0-0.1)
< 0.01 ± 0.00
(0-0.01)
0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
0.1 ± 0.1
(0-0.3)
0.01 ± 0.01
(0-0.01)
Congenital heart defect 20.0 0.1 ± 0.2
(0-0.5)
< 0.01 ± 0.01
(0-0.03)
0.1 ± 0.2
(0-0.4)
< 0.01 ± 0.01
(0-0.02)
0.2 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.03)
- -
Hydranencephalia 20.0 0.1 ± 0.2
(0-0.6)
< 0.01 ± 0.01
(0-0.03)
< 0.1 ± 0.1
(0-0.1)
< 0.01 ± 0.01
(0-0.01)
0.1 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.03)
0.1 ± 0.3
(0-0.6)
0.01 ± 0.01
(0-0.03)
Intussusception 20.0 0.1 ± 0.2
(0-0.5)
< 0.01 ± 0.01
(0-0.028)
0.0 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
0.1 ± 0.2
(0-0.5)
0.01 ± 0.00
(0-0.03)
Omphalitis 46.7 0.1 ± 0.2
(0-0.6)
0.01 ± 0.01
(0-0.03)
0.2 ± 0.1
(0.2–0.4)
< 0.01 ± 0.00
(0.01–0.02)
0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
0.1 ± 0.3
(0-0.6)
0.01 ± 0.01
(0-0.03)
Perforating abomasal ulceration 26.7 0.1 ± 0.2
(0-0.6)
0.01 ± 0.01
(0-0.03)
0.3 ± 0.3
(0-0.6)
0.01 ± 0.02
(0-0.03)
- - 0.0 ± 0.1
(0.0-0.2)
< 0.01 ± 0.01
(0-0.01)
Unknown sudden death 6.7 0.1 ± 0.5
(0-1.8)
0.01 ± 0.03
(0-0.10)
- - - - 0.4 ± 0.8
(0-1.8)
0.02 ± 0.04
(0-0.10)
Iron shock 13.3 < 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.00
(0-0.01)
< 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.00
(0-0.01)
< 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- -
Liver disease 6.7 < 0.1 ± 0.1
(0-0.5)
< 0.01 ± 0.01
(0-0.024)
< 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.00
(0-0.01)
- - 0.1 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.02)
Meningitis 6.7 < 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.00
(0-0.02)
- - 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
- -
Mesenteric torsion 6.7 < 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.00
(0-0.016)
- - - - 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
Necrobacillosis 13.3 < 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
0.0 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- - 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
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Table 1 Mortality risk (%) and rates (cases per 1000 days at risk) in white veal calves by production system (15 cohorts, 5853 calves, 2007-2009, Belgium)
(Continued)
Orchitis 6.7 < 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.00
(0-0.01)
- - < 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- -
Trauma 13.3 < 0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
< 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.014)
0.1 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.012)
- -
Urethra obstruction 6.7 < 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
< 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- - - -
Not autopsied 80.0 0.6 ± 0.6
(0-1.8)
< 0.01 ± 0.03
(0-0.09)
0.8 ± 0.6
(0.2-1.6)
0.04 ± 0.03
(0.01-0.08)
0.2 ± 0.3
(0-0.6)
0.01 ± 0.01
(0-0.03)
0.8 ± 0.7
(0-1.8)
0.04 ± 0.03
(0-0.09)
- = no cases
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production cycle and was almost exclusively due to rum-
inal disorders and enterotoxaemia (Figure 2). Calves
housed in the beef production system were much more
likely to die from enterotoxaemia than dairy (HR = 7.9;
CI = 3.0-20.9; P < 0.01) or crossbred calves (HR = 11.6;
CI = 2.7-49.7; P < 0.01) (Figure 4). Beef calves were also
more likely to die from arthritis, compared to dairy calves
(HR = 5.6; CI = 1.0-30.5; P < 0.05). There was no signifi-
cant effect of the production system on other causes of
mortality. Significant herd effects (P < 0.05) were noted
for total mortality, pneumonia, ruminal disorders, death
at arrival and idiopathic peritonitis.
Detailed necropsies and additional virological and
bacteriological investigations
From 91 necropsied calves (30%; 91/308) additional sam-
ples for bacteriology and virology were taken. Of these
calves, 57.1% (52/91) showed lesions of pneumonia,
49.5% (45/91) enteritis (21 catarrhal enteritis and 24
hemorrhagic enteritis), 16.5% (15/91) frothy ruminal
bloat, 14.3% (13/91) idiopathic peritonitis, 26.4% (23/91)
abomasal ulcerations (3 with perforating ulceration and
generalized peritonitis), 19.8% (18/91) fibrinous pleuritis,
5.5% (5/91) pericarditis, 4.4% (4/91) congenital heart
defects (3 interventricular septum defects, 1 tetralogy of
Fallot), 4.4% (4/91) omphalitis (2 umbilical abscesses, 1
omphalophlebitis with liver abscesses and 1 omphaloar-
teritis) and 3.2% (3/91) an intussusception. Arthritis,
meningitis, hydronephros, abomasal displacement, fistu-
lating hepatitis or orchitis each accounted for one calf.
Concurrent enteritis and pneumonia occurred in 22
(24.2%) cases, but the association was not significant. Of
the 22 young (< 5 weeks old) calves with enteritis, 50%,
18.1%, 13.6% and 4.6% were Cryptosporidium parvum,
bovine rotavirus, bovine coronavirus and Escherichia coli
F5 positive respectively. Salmonella spp. could not be
cultured from any of the examined (n = 13) cases with
suspicious lesions.
In 92.3% (48/51) of the pneumonia cases a bacterial
bronchopneumonia (of which 9 showed pulmonary
abcessation) and only in 7.7% (4/51) an acute interstitial
pneumonia was found. Chronic pneumonia was asso-
ciated with fibrinous pleuritis in 17 (33.3%) cases (odds
ratio (OR) = 9.2; CI = 2.9-29.1; P < 0.01). Pericarditis was
associated with pleuritis (OR = 20.6; CI = 2.1-198.0; P <
0.01). From pneumonia cases Mannheimia haemolytica
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Figure 1 Mortality risk (%) of pneumonia and idiopathic peritonitis according to week on feed in 5853 white veal calves, housed in
15 cohorts in Belgium (2007-2009).
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Figure 2 Mortality risk (%) of selected digestive diseases according to week on feed in 5853 white veal calves, housed in 15 cohorts
in Belgium (2007-2009).
Figure 3 Survival distribution function for mortality in white
veal calves by production system (15 cohorts, 5853 calves,
2007-2009, Belgium).
Figure 4 Survival distribution function for enterotoxaemia in
white veal calves by production system (15 cohorts, 5853
calves, 2007-2009, Belgium).
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(19.4%; 7/36), Pasteurella multocida (22.2%; 8/36), E. coli
(30.6%; 11/36), Arcanobacterium pyogenes (25.0%; 9/36)
and Mycoplasma spp. (33.3%; 11/33) were isolated.
Detection of A. pyogenes was associated with pulmonary
abcessation (OR = 15.6; CI = 2.2-109.8; P < 0.01). In 14
cases of acute pneumonia additional virological assays
were performed. Of these cases, 35.7% was bRSV PCR
positive, whereas BHV-1, PI-3 and BAV-3 were not
detected. Overall, 26.0% (19/73) of the examined calves
were BVDV PCR positive. A positive BVDV test was
associated with chronic pneumonia (OR = 21.6; CI = 5.7-
81.9; P < 0.01) and pleuritis (OR = 4.9; CI = 1.5-16.3; P <
0.01). Of the 13 cases, classified as idiopathic peritonitis,
8 showed concurrent pneumonia, 4 pleuritis and 1 peri-
carditis. There were no significant associations between
the presence of peritonitis on the one hand and pneumo-
nia, pleuritis, pericarditis or abomasal ulcerations on the
other hand. Bacteriology of abdominal fluid was per-
formed in 3 cases and yielded two times M. haemolytica
and once E. coli.
Morbidity
Altogether, 25.4% (896/3519) of the calves developed one
or more diseases between arrival and slaughter. The aver-
age morbidity risk at the cohort level was 25.0% (SD =
12.9; R = 9.6-45.7) and the morbidity rate was 1.7 calves
per 1000 days at risk (SD = 1.0; R = 0.6-3.1). In Table 2
incidence risk and rates of all individually treated diseases
are given by production system. BRD occurred most fre-
quently (56.1% of the initial cases), followed by diarrhea
(18.5%), scabies (6.3%, exclusively Belgian Blue), otitis
(5.7%) and arthritis (5.5%). The proportion of reoccurent
cases was on average 9.3% (SD = 8.8; R = 0-24.3) for
BRD, 18.8% (SD = 23.9; R = 0-50.0) for necrobacillosis
and 0.2% (SD = 0.7; R = 0-2.3) for diarrhea. For other dis-
eases there were no reoccurent cases. The proportion of
relapse cases was 10.2% (SD = 6.1; R = 2.4-20.9) for BRD,
31.3% (SD = 47.3; 0-100.0) for necrobacillosis and 1.3%
(SD = 4.0; 0-12.5) for arthritis. Case fatality rate was on
average 7.8% (SD = 7.5; R = 0-25.0) for BRD, 25.4% (SD
= 33.2; R = 0-100) for arthritis, 6.3% (SD = 12.5; R = 0-
50.0) for necrobacillosis, 9.4% (SD = 20.6; 0-66.7) for
diarrhea and 42.2% (SD = 51.8; R = 0-100.0) for idio-
pathic peritonitis.
Morbidity peaked in the first 3 weeks after arrival, gra-
dually declined and after week 24 hardly any treatments
were initiated (Figure 5). There was no significant differ-
ence in total morbidity between the production systems.
Diarrhea mainly occurred in the first three weeks after
arrival. BRD already occurred immediately after arrival,
but the peak incidence occurred at week 3 (Figure 5).
Only arthritis was significantly more frequently treated in
beef cohorts compared to dairy (OR = 5.3; CI = 1.7-16.8;
P < 0.01) or crossbreds (OR = 3.5; CI = 1.2-10.5; P <
0.01). Mange was only a problem in Belgian Blue beef
calves. The two peaks near the end of the production
cycle (day 156 and 166) were due to individual adminis-
tration of macrocyclic lactones for mange treatment to a
large proportion of Belgian Blue calves in cohort 10.
There were no other significant associations between
production system and diseases. Significant herd effects
were detected for total morbidity and all other assessed
diseases.
Discussion
Random sampling is the method of choice to obtain a
representative sample of the population [31]. In the pre-
sent study herds were conveniently selected based upon
motivation, as was done in previous studies to guarantee
an adequate follow up and to minimize data loss
[3,8,10,13,32-35]. Because the sample size included 5% of
the population with more than 90% of the active veteri-
narians and integrators represented, and because housing
and feeding are highly standardized in the Belgian veal
industry, the possible selection bias, caused by this selec-
tion procedure, is believed to be limited. Because of the
convenience selection the sample can only be assumed
indicative but not representative for the complete Belgian
veal industry at present. The estimation of morbidity was
based upon individual treatment by the producer, assum-
ing that treatment rates accurately reflected illness and
that increased treatment rates indicated a higher degree
of morbidity at that time [10,33]. Antimicrobial use is
however influenced by socioeconomic factors and also
the personal attitude of the producer might have influ-
enced the difference in treatment rates between the
farms [36]. Since easily administrable oral group treat-
ments are frequently used throughout the production
cycle, farmers only tended to individually treat calves
when severely ill or when only few calves require treat-
ment [21]. In that respect, the individual calf treatments
do reflect severe individual calf illness as perceived by the
producers.
In the present study, the mortality risk (5,3%) was
higher than previously reported for white veal calves in
Canada (3,7%), the United States (2,5% and 4,2%) and
Switzerland (3,0%) [10,11,13,37]. Including beef cohorts
in the present study might explain the higher losses com-
pared to studies on dairy veal calves only, since beef
calves are more likely to die [38,39]. However, also the
mortality risk within the dairy calves was relatively high
(4,9%) compared to previous studies. The most likely
explanation is probably the longer production cycle (28
weeks) compared to previously studied systems (16-21
weeks), which increased the days at risk. A second expla-
natory factor might be the housing system. In the older
studies, calves were housed in individual stalls during the
complete production cycle. It was postulated that this
Pardon et al. BMC Veterinary Research 2012, 8:26
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Table 2 Incidence risk (%) and rates (cases per 1000 days at risk) of individually treated diseases in 3519 white veal calves by production system (10 cohorts,
2007-2009, Belgium)a
Disease Total (n = 3519) Dairy (n = 1429) Crossbreds (n = 996) Beef (n = 1094)
Percentage of cohorts affected Incidence risk
mean ± SD
(min-max)
Incidence rate
mean ± SD
(min-max)
Incidence risk
mean ± SD
(min-max)
Incidence rate
mean ± SD
(min-max)
Incidence risk
mean ± SD
(min-max)
Incidence rate
mean ± SD
(min-max)
Incidence risk
mean ± SD
(min-max)
Incidence rate
mean ± SD
(min-max)
Total morbiditya 100 31.0 ± 17.4
(11.2-57.3)
1.66 ± 0.97
(0.57-3.14)
26.1 ± 21.8
(11.2-51.1)
1.45 ± 1.23
(0.57-2.86)
26.6 ± 19.3
(15.4-48.8)
1.39 ± 1.05
(0.78-2.60)
38.0 ± 15.2
(20.8-57.3)
2.03 ± 0.88
(1.05-3.14)
Respiratory disease 100 17.9 ± 9.6
(8.2-33.9)
0.95 ± 0.52
(0.41-1.79)
16.8 ± 9.7
(8.3-27.4)
0.93 ± 0.55
(0.42-1.52)
17.3 ± 14.4
(8.2-33.9)
0.90 ± 0.77
(0.41-1.79)
19.1 ± 8.3
(10.8-28.9)
1.00 ± 0.45
(0.58-1.56)
Diarrhea 100 5.7 ± 3.8
(0-0.5)
0.30 ± 0.20
(0.01-0.61)
3.3 ± 3.9
(0.2-7.7)
0.18 ± 0.22
(0.01-0.42)
6.5 ± 2.3
(4.5-9.1)
0.03 ± 0.13
(0.22-0.47)
7.1 ± 4.5
(1.0-11.4)
0.37 ± 0.24
(0.05-0.61)
Arthritis 100 2.0 ± 2.3
(0.2-7.8)
0.11 ± 0.12
(0.01-0.42)
0.8 ± 0.7
(0.2-1.6)
0.04 ± 0.04
(0.01-0.09)
1.0 ± 0.7
(0.3-1.8)
0.05 ± 0.04
(0.02-0.09)
3.7 ± 2.9
(1.1-7.8)
0.19 ± 0.16
(0.06-0.42)
Scabies 20 1.6 ± 4.4
(0-14.1)
0.09-0.24
(0-0.75)
- - - - 4.1 ± 6.7
(0-14.1)
0.22 ± 0.36
(0-0.75)
Otitis 80 1.3 ± 2.2
(0-2.0)
0.07 ± 0.12
(0-0.40)
2.7 ± 4.1
(0-7.4)
0.15 ± 0.22
(0-0.40)
1.0-0.7
(0.3-1.8)
0.05-0.04
(0.02-0.09)
0.4 ± 0.3
(0-0.6)
0.02 ± 0.01
(0-0.03)
Ruminal drinking 40 0.8-1.7
(0-5.4)
0.04 ± 0.09
(0-0.29)
0.7 ± 1.0
(0-1.8)
0.04 ± 0.05
(0-0.10)
- - 1.5 ± 2.6
(0-5.4)
0.08 ± 0.14
(0-0.29)
Necrobacillosis 40 0.4 ± 0.6
(0-1.6)
0.02 ± 0.03
(0-0.08)
0.1 ± 0.2
(0-0.4)
0.01 ± 0.01
(0-0.02)
- - 0.8 ± 0.7
(0-1.6)
0.04 ± 0.03
(0-0.08)
Idiopathic peritonitis 30 0.3 ± 0.8
(0-2.6)
0.02 ± 0.04
(0-0.14)
0.9 ± 1.5
(0-2.6)
0.05 ± 0.08
(0-0.14)
0.1 ± 0.2
(0-0.3)
0.01 ± 0.01
(0-0.02)
0.1 ± 0.2
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
Omphalitis 30 0.3 ± 0.7
(0-2.0)
0.02 ± 0.03
(0-0.11)
0.4 ± 0.4
(0-0.7)
0.02 ± 0.02
(0-0.04)
0.7 ± 1.2
(0-2.0)
0.04 ± 0.06
(0-0.11)
- -
Internal hemorrhage 20 0.2 ± 0.4
(0-1.2)
0.01 ± 0.02
(0-0.07)
0.4 ± 0.7
(0-1.2)
0.02 ± 0.04
(0-0.07)
- - 0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
Colic 30 0.1 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.03)
- - - - 0.3 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.03)
Growth retardation 20 0.1 ± 0.4
(0-1.2)
0.01 ± 0.02
(0-0.06)
- - - - 0.3 ± 0.6
(0-1.2)
0.02 ± 0.03
(0-0.06)
Abcessation 10 0.1 ± 0.2
(0-0.5)
< 0.01 ± 0.01
(0.01-0.42)
- - - - 0.1 ± 0.3
(0-0.5)
0.01 ± 0.01
(0-0.03)
Neurological symptoms 10 0.1 ± 0.2
(0-0.6)
0.01 ± 0.01
(0-0.03)
- - - - 0.2 ± 0.3
(0-0.6)
0.01 ± 0.02
(0-0.03)
Enterotoxaemia 20 0.05 ± 0.1
(0-0.5)
< 0.01 ± 0.01
(0-0.02)
- - - - 0.1 ± 0.2
(0-0.5)
0.01 ± 0.01
(0-0.02)
Trauma 10 0.03 ± 0.1
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
- - - - 0.1 ± 0.2
(0-0.3)
< 0.01 ± 0.01
(0-0.02)
Eye inflammation 10 0.02 ± 0.1
(0-0.2)
< 0.01 ± < 0.01
(0-0.01)
0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- - - -
Iron shock 10 0.02 ± 0.1
(0-0.2)
< 0.01 ± < 0.01
(0-0.01)
0.1 ± 0.1
(0-0.2)
< 0.01 ± 0.01
(0-0.01)
- - - -
a Calves could have more than one disease. Both initial and relapse cases were included. - = no cases; SD = standard deviation
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creates a higher opportunity for individual monitoring
and care compared to contemporary group housing [11].
Also the possibility to control feed uptake in individually
housed calves might have been a protective factor, since
the mortality risk of digestive diseases was far smaller
(19,2%) in individual housing, compared to group hous-
ing in Belgium and Switzerland (41,9% and 52,0% respec-
tively) [13]. The exact influence of the housing type on
mortality remains unclear, since individual housing is
nowadays forbidden and previous comparative studies
did not report mortality data [40]. Nevertheless, the
Swiss study shows that low mortality risks can be
achieved in group housing in large pens. However, the
fact that in that study, calves were purchased within a
day, at a minimum age of three weeks and were housed
at low stocking density (> 3,5 m2/calf) most likely also
contributed to the lower mortality risk.
High mortality risks (8.2%) have been reported in farms
which purchase young calves from different origin [41].
Surprisingly, the mortality risk in veal calves was similar
to live born calves in dairy replacement herds in Great
Britain (5.0%), Norway (4,6%), Sweden (4.0%) and
crossbred cow-calf farms in Switzerland (5.0%) and even
smaller than reported in large scale dairy calf rearing in
Northern America (7,6% and 13,3%) [2,3,7,9,35,42]. Veal
producers in Belgium appear to be reasonably able to
manage and care for the young, highly stressed calves
from multiple origin. However, compared to conven-
tional calf rearing, preventive and metaphylactic antimi-
crobial drug use plays an important role in this
management [21]. Whether the current mortality risk
can be maintained with less antimicrobial use is an
important question for future research.
Compared to North American (5,5%) or Australian
bobby calves (0,6%), transport related mortality was low
in Belgian veal calves (0.3%), most likely due to shorter
transportation times [43,44]. The finding of hydranence-
phalia in several dummy calves, was associated with the
2007 bluetongue outbreak in Northern Europe and illus-
trates how close monitoring of veal calves can assist in
the detection of calf diseases of global interest [45]. Diar-
rhea and related mortality was mainly an issue in the first
weeks after arrival, consistent with the risk period in con-
ventional calf rearing [2]. The incidence rate of diarrhea
(0,30 cases per 1000 calf days at risk) was smaller than in
Swedish (1.17) and North American (1.50) dairy calves,
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Figure 5 Incidence risk (%) of individually treated diseases according to days on feed in 3519 white veal calves, housed in 10 cohorts
in Belgium (2007-2009). A calf was considered morbid on a given day when individually treated with a single or multiple, antimicrobial or
non-antimicrobial drug, taking the prolonged effect of the mentioned antimicrobials into account.
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most likely because calves were also monitored in the
neonatal period in the latter studies [2,7,8,46]. All major
pathogens of the neonatal enteritis complex were found
and surprisingly also E. Coli F5, suggesting that certain
calves were much younger than two weeks old. Although
Salmonella spp. are historically reported as one of the
major causes of mortality in veal calves in Belgium and
recent studies still confirmed its presence on Danish veal
herds, the bacteria could not be isolated from any of the
suspicious cases [47-49]. In contrast to conventional
dairy calves, diarrhea and respiratory disease occurred
simultaneously in the first three weeks after arrival,
which is most likely a consequence of commingling
[8,13,50].
BRD was the leading cause of morbidity and mortality.
The incidence rate (0,95 cases per 1000 calf days at risk)
was similar to Swedish (0.83; measured between birth and
13 weeks of age) or Minnesota dairy calves (1.00; mea-
sured between birth and 16 weeks of age), but smaller
than in non-weaned Charolais calves in cow-calf herds
(1,89; measured between birth and 26 weeks maximum)
[2,8,28]. Given the large amount of oral group antimicro-
bial treatments administered for respiratory disease in veal
calves, the incidence is probably severely underestimated
and a lot more calves is expected to have suffered from
respiratory disease than indicated by individual treatment
[51]. Peak incidences of BRD were reached 2 to 6 weeks
after arrival, which is at younger age than conventionally
housed dairy heifer calves (10 weeks) [2]. Commingling of
calves is a major risk factor for BRD, and the peak inci-
dence of respiratory disease is expected immediately after
arrival [50,52]. Metaphylactic treatment at arrival, gradual
decline of maternal immunity, incomplete maturation of
the immune system and the slowly progressive nature of
the dominant pathogens in European veal production,
namely Mycoplasma bovis and BVDV, might have influ-
enced the occurrence of the peak incidence at the age of
1-1.5 months instead of at arrival [24,53-55]. In contrast
to cow-calf herds where the BRD incidence remains at a
higher level (1.0%), hardly any veal calves still require indi-
vidual treatment after 3 months of age [2,28]. Most likely
the similar age and the all-in all-out management of veal
calves limit respiratory disease to the first two months
after arrival, whereas in conventional herds pathogens can
constantly be transferred from older to younger calves.
The long tail of the BRD mortality and morbidity curve is
explained by a large proportion of chronic BRD cases
(reoccurent and relapse). In addition to previous work, the
present study confirms the association of BVDV with
chronic pneumonia lesions and pleuritis in white veal
calves [24]. As in feedlot calves, the synergy between
M. bovis and BVDV is the cause of chronic, unresponsive
pneumonia, often in association with arthritis and otitis
(M. bovis associated disease) [24,53,56,57]. In this respect,
the higher incidence of arthritis and otitis compared to
conventional calves is most likely the consequence of the
high prevalence of M. bovis in white veal cohorts [8]. In
the present study crossbreds had marked lower mortality
due to respiratory disease. This heterosis effect has also
been observed in other production systems [38,39,58].
As mentioned earlier, digestive diseases were an more
important cause of mortality in the recent studies on
group housed calves, compared to an older study on indi-
vidually housed calves [10,13]. In group housed veal calves
in Switzerland, much more calves died from perforating
abomasal ulceration (0.53% vs. 0.11% in the present study)
and intestinal torsion (0.4% vs. 0.02%) compared to group
housed calves in Belgium [13]. In contrast very few calves
(0.14%) died from ruminal bloat in Switzerland, whereas
ruminal bloat (0.7%) and enterotoxaemia (0.5%) were the
most important digestive causes of mortality in Belgium
[13]. Although both diseases occurred throughout the pro-
duction cycle, the main risk period was situated near the
end of the production round, when feed uptake was at its
highest. In contrast to ruminal disorders, enterotoxaemia
almost exclusively occurred in Belgian Blue veal calves.
The causative agent is Clostridium perfringens, but the
identity of the toxin and the exact pathogenesis are still
unclear [59,60]. Also Belgian Blue suckler calves are highly
susceptible for enterotoxaemia, and it is unclear whether
there is a breed predisposition or whether dietary differ-
ences between the studied production systems are the
cause [61].
Finally, one of the most remarkable causes of mortality
in the present study, was idiopathic peritonitis, especially
in dairy veal calves. Idiopathic peritonitis emerged only
recently in veal calves and the peak incidence at week 9,
shortly after the respiratory problems, suggests septicemic
spread of bacteria from the lungs to the peritoneum. In
one outbreak in Belgium P. multocida capsular type F has
been isolated from peritoneal fluid in two cases [62]. Also,
P. multocida capsular type B was isolated from outbreaks
of pleuritis and peritonitis in intensive dairy calf rearing
facilities in New Zealand [63]. In the present study no sig-
nificant association between pneumonia and peritonitis
could be demonstrated at necropsy and only M. haemoly-
tica and E. coli could be isolated from peritoneal fluid.
Given these contradictory necropsy results, and the identi-
fication of a specific risk period in the present study, more
research is necessary to identify the aetiology of idiopathic
peritonitis.
Conclusions
The present study offers a benchmark for morbidity and
mortality data in the most common housing system for
white veal calves in Europe, based upon the Belgian situa-
tion. Respiratory disease was the leading cause of morbid-
ity and mortality. BVDV was associated with chronic
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pneumonia and pleuritis at necropsy. Calves housed in
beef cohorts were at higher risk to die from pneumonia,
enterotoxaemia and arthritis. This information can be
used to evaluate preventive and therapeutic protocols and
can direct producers towards the most profitable strategy
with attention for public health and animal welfare.
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